Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE), thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement, Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after MI
